Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03903692 · ClinicalTrials.gov registry record · NA

A Comparative Evaluation of a MPS Dressing and a CMC Dressing on Subjects With Lower Extremity Venous Ulcers

A NA study, sponsored by Medline Industries.

Terminated
Registry status
NA
Development phase
62
Enrollment target

NCT03903692 is a NA study that was terminated before completion, run by Medline Industries. The registered enrollment target is 62 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03903692, a NA study, was terminated before completion, sponsored by Medline Industries.

TERMINATED
Registry status
NA
Development phase
62 participants
Enrollment target

Study Summary

Venous leg ulcers are lower extremity ulcers that develop due to sustained venous hypertension resulting from chronic venous insufficiency. Varicose veins, deep vein thrombosis, poor calf muscle function, arterio-venous fistulae, obesity and history of leg fracture are some of the risk factors for venous ulceration. Numerous dressing types exist to treat these ulcers. This study will compare a marine polysaccharide (MPS) dressing to a carboxymethylcellulose dressing to determine which dressing better manages these wounds with regard to wound size and periwound skin condition. Subjects will be randomized to receive either MPS-Ag dressing or CMC-Ag dressing.

Interventions

  • DEVICE Marine polysaccharide dressing
  • DEVICE Carboxymethylcellulose dressing

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2019-09-30
Est. Completion 2022-12-21
Phase NA

Sponsor

Medline Industries

24 total trials

What the Registry Record Tells You About NCT03903692

The ClinicalTrials.gov registry entry for NCT03903692 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medline Industries, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Marine polysaccharide dressing is the first listed.

NCT03903692 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03903692 about?

NCT03903692 is a clinical study titled "A Comparative Evaluation of a MPS Dressing and a CMC Dressing on Subjects With Lower Extremity Venous Ulcers". Venous leg ulcers are lower extremity ulcers that develop due to sustained venous hypertension resulting from chronic venous insufficiency. Varicose veins, deep vein thrombosis, poor calf muscle function, arterio-venous fistulae, obesity and history of leg fracture are some of the risk factors for v...

What is the current status of trial NCT03903692?

This trial is currently terminated. It is a NA study. The enrollment target is 62 participants. The study started on 2019-09-30. Estimated completion is 2022-12-21.

What interventions are being tested in trial NCT03903692?

The interventions under investigation include: Marine polysaccharide dressing (DEVICE), Carboxymethylcellulose dressing (DEVICE).

Who is sponsoring clinical trial NCT03903692?

This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.